Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024. Which stocks will surge next? Unlock AI-picked Stocks
Close

Crispr Therapeutics AG (CRSP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Crispr Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
55.65 -0.76    -1.35%
24/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
54.88
-0.77
-1.38%
14:17:33 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 910,797
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 55.50 - 57.78
Crispr Therapeutics 55.65 -0.76 -1.35%

CRSP Balance Sheet

 
Featured here, the Balance Sheet for Crispr Therapeutics AG, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 1908.08 1760.59 1859.57 1907.97
Cash and Short Term Investments 1693.69 1739.83 1768.1 1883.17
Cash - - - -
Cash & Equivalents 389.48 527.76 444.8 344.41
Short Term Investments 1304.22 1212.06 1323.31 1538.76
Total Receivables, Net 206.5 - 70 -
Accounts Receivables - Trade, Net 200 - 70 -
Total Inventory - - - -
Prepaid Expenses 7.89 20.76 21.47 24.8
Other Current Assets, Total - - - -
Total Assets 2229.57 2086.83 2197.01 2244.36
Property/Plant/Equipment, Total - Net 305.94 312.34 318.52 315.54
Property/Plant/Equipment, Total - Gross 359.37 360.88 362.34 354.41
Accumulated Depreciation, Total -53.43 -48.55 -43.82 -38.87
Goodwill, Net - - - -
Intangibles, Net 0.016 0.03 0.043 0.057
Long Term Investments 1.97 - 4.9 6.32
Note Receivable - Long Term 6.5 - - -
Other Long Term Assets, Total 13.57 13.88 13.97 14.48
Other Assets, Total 1097.72 1212.06 1253.31 1538.76
Total Current Liabilities 108.79 111.23 132.84 146.79
Accounts Payable 38.15 26.15 27.59 45.15
Payable/Accrued - - - -
Accrued Expenses 40.67 38.6 40.39 36.87
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 15.62 15 14.83 15.72
Other Current liabilities, Total 14.35 31.48 50.03 49.05
Total Liabilities 346.77 359.04 380.99 389.47
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 237.98 247.8 248.15 242.67
Total Equity 1882.8 1727.79 1816.03 1854.9
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 2.5 2.48 2.47 2.45
Additional Paid-In Capital 2878.16 2821.22 2799.42 2761.05
Retained Earnings (Accumulated Deficit) -999.7 -1089.05 -976.9 -899.16
Treasury Stock - Common -0.062 -0.063 -0.063 -0.063
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 1.91 -6.8 -8.91 -9.39
Total Liabilities & Shareholders' Equity 2229.57 2086.83 2197.01 2244.36
Total Common Shares Outstanding 80.04 79.43 79.37 78.86
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CRSP Comments

Write your thoughts about Crispr Therapeutics AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email